Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Current Pharmacology Reports|March 7, 2017
Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current OpportunitiesStephen Fowler, Peter N Morcos, Yumi Cleary, et al.
Clinical Pharmacokinetics|September 6, 2015
Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling PredictionsChristophe Boetsch, Neil Parrott, Stephen Fowler, et al.
Clinical Pharmacokinetics|December 31, 2015
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an ExampleSheng Feng, Jun Shi, Neil Parrott, et al.
British Journal of Clinical Pharmacology|June 6, 2002
Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor ELMeret Martin-Facklam, Jürgen Burhenne, Reinhard Ding, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Inhibition of P-glycoprotein by newer antidepressantsJohanna Weiss, Sven-Maria Gregor Dormann, Meret Martin-Facklam, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 27, 2025
PD-1-Cis IL-2R Agonism Determines the Predicted Pharmacological Dose Range for the Immunocytokine Eciskafusp Alfa (PD1-IL2v)Lucy G Hutchinson, Thomas D Lewin, Laura Lauener, et al.
European Journal of Clinical Pharmacology|December 16, 2004
Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?Meret Martin-Facklam, Jens Rengelshausen, Yorki Tayrouz, et al.
British Journal of Clinical Pharmacology|March 5, 2004
Oral contraception does not alter single dose saquinavir pharmacokinetics in womenMargit Fröhlich, Jürgen Burhenne, Meret Martin-Facklam, et al.
Psychopharmacology|May 15, 2016
Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteersCarsten Hofmann, Flavia Pizzagalli, Christophe Boetsch, et al.
European Journal of Clinical Pharmacology|June 16, 2004
High prevalence of unknown co-medication in hospitalised patientsKarin Rieger, André Scholer, Isabelle Arnet, et al.
Pageof 4